SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-12-15 15:04
Tx date 2022-12-12 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
56 - Grant of rights 		$3,277,790
+327,779 vol
$10.00 each 		527,020
Filed 2021-12-14 15:17
Tx date 2020-06-25 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
-65,000 vol 		0
Filed 2021-12-14 15:16
Tx date 2019-06-25 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
-195,000 vol 		65,000
Filed 2021-12-10 14:37
Tx date 2021-12-08 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
56 - Grant of rights 		$1,392,410
+139,241 vol
$10.00 each 		459,241
Filed 2021-12-10 14:36
Tx date 2021-12-08 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$3,040,358
+201,215 vol
$15.11 each 		720,461
Filed 2021-12-08 15:09
Tx date 2021-12-08 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$75,325
+5,000 vol
$15.06 each 		25,000
Filed 2021-08-20 12:28
Tx date 2021-08-20 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$35,000
+2,000 vol
$17.50 each 		20,000
Filed 2020-11-13 14:48
Tx date 2020-11-09 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
56 - Grant of rights 		$600,000
+60,000 vol
$10.00 each 		320,000
Filed 2020-11-13 12:38
Tx date 2020-11-09 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,011,400
+65,000 vol
$15.56 each 		519,246
Filed 2020-11-09 11:12
Tx date 2020-11-09 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$131,200
+8,000 vol
$16.40 each 		18,000
Filed 2019-08-19 14:47
Tx date 2019-08-19 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$70,045
+4,900 vol
$14.30 each 		10,000
Filed 2019-08-19 14:46
Tx date 2019-08-19 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,415
+100 vol
$14.15 each 		5,100
Filed 2019-06-11 10:49
Tx date 2019-06-07 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,661,144
+106,826 vol
$15.55 each 		454,246
Filed 2018-08-23
Tx date 2018-08-22 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$784,894
+94,112 vol
$8.34 each 		347,420
Filed 2018-05-24
Tx date 2018-05-24 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$33,250
+3,500 vol
$9.50 each 		5,000
Filed 2018-05-24
Tx date 2018-05-24 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$11,280
+1,200 vol
$9.40 each 		1,500
Filed 2018-05-24
Tx date 2018-05-24 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,790
+300 vol
$9.30 each 		300
Filed 2018-05-24
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-14
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
00 - Opening Balance-Initial SEDI Report 		260,000
Filed 2018-03-14
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		253,308
Filed 2018-03-14
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Godin, Gilbert
5 - Senior Officer of Issuer
Holder: Kingsbarn Ventures, LLC (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		902,000